PhaseBio Pharmaceuticals, Inc.
(NASDAQ : PHAS)

( )
PHAS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.53%35.180.9%$1221.11m
JNJJohnson & Johnson
0.68%132.250.7%$898.76m
MRKMerck & Co., Inc.
1.31%86.170.6%$797.92m
BMYBristol-Myers Squibb Company
1.02%47.461.4%$680.93m
ABBVAbbVie, Inc.
3.23%66.512.3%$635.12m
LLYEli Lilly and Company
1.81%112.521.0%$459.39m
NVSNovartis AG Sponsored ADR
0.01%89.480.2%$184.97m
AZNAstraZeneca PLC Sponsored ADR
0.19%44.431.2%$164.25m
GSKGlaxoSmithKline plc Sponsored ADR
0.46%40.380.3%$97.17m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.87%51.210.1%$78.17m
SNYSanofi Sponsored ADR
1.69%42.730.2%$51.63m
LCILannett Company, Inc.
2.07%6.9136.6%$11.34m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.52%1.931.6%$3.82m
EPIXESSA Pharma Inc
20.53%1.820.1%$0.04m

Company Profile

PhaseBio Pharmaceuticals, Inc. is engaged in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.